RiverPark Advisors, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
RiverPark Advisors, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$866,000
-29.9%
20,132
-19.9%
0.38%
+28.4%
Q3 2018$1,235,000
+32.5%
25,118
-13.6%
0.30%
+56.6%
Q2 2018$932,000
+88.7%
29,071
+83.5%
0.19%
+98.9%
Q1 2018$494,000
-59.7%
15,846
-51.4%
0.10%
-41.0%
Q3 2017$1,225,000
-21.3%
32,6240.0%0.16%
-9.0%
Q2 2017$1,556,000
+4.6%
32,6240.0%0.18%
+80.6%
Q1 2017$1,488,000
+41.2%
32,6240.0%0.10%
-82.3%
Q4 2016$1,054,000
-5.6%
32,6240.0%0.56%
+128.4%
Q3 2016$1,116,000
+1.5%
32,6240.0%0.24%
-54.9%
Q2 2016$1,100,000
-36.3%
32,6240.0%0.54%
-33.6%
Q1 2016$1,728,00032,6240.81%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders